CLU and colon cancer. The dual face of CLU: From normal to malignant phenotype

Advances in Cancer Research

Volumn 105, Issue , 2009, Pages 45-61

  Mazzarelli, P ^a   Pucci, Sabina ^a   Spagnoli, L G ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BAX PROTEIN, HUMAN; CELL NUCLEUS ANTIGEN; CLU PROTEIN, HUMAN; CLUSTERIN; DNA BINDING PROTEIN; KU ANTIGEN; PROTEIN BAX; TUMOR MARKER;

APOPTOSIS; COLON TUMOR; DISEASE COURSE; DNA DAMAGE; DNA REPAIR; GENETICS; HUMAN; PHENOTYPE; PHYSIOLOGY; REVIEW;

ANTIGENS, NUCLEAR; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CLUSTERIN; COLONIC NEOPLASMS; DISEASE PROGRESSION; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; HUMANS; PHENOTYPE; TUMOR MARKERS, BIOLOGICAL;

EID: 73949090072     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-230X(09)05003-9     Document Type: Article

References (30)

1. Blunt, T., Finnie, N. J., Taccioli, G. E., Smith, G. C., Demengeot, J., and Gottlieb, T. M. (1995). Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 80, 813-823.
2. Chen, X., Halberg, R. B., Ehrhardt, W. M., Torrealba, J., and Dove, W. F. (2003). Clusterin as a biomarker in murine and human intestinal neoplasia. PNAS 100(16), 9530-9535.
3. Chen, T., Turner, J., McCarthy, S., Scaltriti, M., Bettuzzi, S., and Yeatman, T. J. (2004). Clusterinmediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent. Cancer Res. 64(20), 7412-7419.
4. Cohen, H. Y., Lavu, S., Bitterman, K. J., Hekking, B., Imahiyerobo, T. A., Miller, C., Frye, R., Ploegh, H., Kessler, B. M., and Sinclair, D. A. (2004). Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol. Cell 13, 627-638.
5. Difilippantonio, M. J., Zhu, J., Chen, H. T., Meffre, E., Nussenzweig, M. C., Max, E. E., Ried, T., and Nussenzweig, A. (2000). DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 404, 510-514.
6. Evan, G. I., and Vousden, K. H. (2001). Proliferation cell cycle and apoptosis in cancer. Nature 441, 342-348.
7. Fewell, J. W., and Kuff, E. L. (1996). Intracellular redistribution of Ku immunoreactivity in response to cell-cell contact and growth modulating components in the medium. J. Cell Sci. 109, 1937-1946.
8. Gottlieb, T. M., and Jackson, S. P. (1993). The DNA dependent protein kinase: Requirement for DNA ends and association with Ku antigen. Cell 72, 131-142.
9. Gryfe, R., Swallow, C., Bapat, B., Redston, M., and Gallinger, S. (1997). Couture molecular biology of colorectal cancer. 5. J. Curr. Probl. Cancer 21, 233-300.
10. Jackson, S. P., and Jeggo, P. A. (1995). DNA double-strand break repair and V(D)J recombination: Involvement of DNA-PK. Trends Biochem. Sci. 20, 412-415.
11. Kevans, D., Foley, J., Tenniswood, M., Sheahan, K., Hyland, J., O'Donoghue, D., Mulcahy, H., and O'Sullivan, J. (2009). High clusterin expression correlates with a poor outcome in stage II colorectal cancers. Cancer Epidemiol. Biomarkers Prev. 18, 393-399.
12. Koike, M., Awaji, T., Kataoka, M., Tsujimoto, G., Kartasova, T., Koike, A., and Shiomi, T. (1999). Differential subcellular localization of DNA-dependent protein kinase components Ku and DNA-PKcs during mitosis. J. Cell Sci. 112(Pt. 22), 4031-4039.
13. Leskov, K. S., Klokov, D. Y., Li, J., Kinsella, T. J., and Boothman, D. A. (2003). Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem. 278, 11590-11600.
14. Loukola, A., Vilkki, S., Singh, J., Launonen, V., and Aaltonen, L. A. (2000). Germline and somatic mutation analysis of MLH3 in MSI-positive colorectal cancer. Am. J. Pathol. 157(2), 347-352.
15. Morrissey, C., Lakins, J., Moquin, A., Hussain, M., and Tenniswood, M. (2001). An antigen capture assay for the measurement of serum clusterin concentrations. J. Biochem. Biophys. Methods 48, 13-21.
16. O'Sullivan, J., Whyte, L., Drake, J., and Tenniswood, M. (2003). Alterations in the posttranslational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis. Cell Death Differ. 10, 914-927.
17. Prabhakar, B. S., Allaway, G. P., Srinivasappa, J., and Notkins, A. L. (1990). Cell surface expression of the 70-kDa component of Ku, a DNA-binding nuclear autoantigen. J. Clin. Invest. 86, 1301-1305.
18. Pucci, S., Mazzarelli, P., Rabitti, C., Giai, M., Gallucci, M., Flammia, G., Alcini, A., Altomare, V., and Fazio, V. M. (2001). Tumor specific modulation of Ku70/80 DNA binding activity in breast and bladder human tumor biopsies. Oncogene 20, 739-747.
19. Pucci, S., Bonanno, E., Pichiorri, F., Angeloni, C., and Spagnoli, L. G. (2004a). Modulation of different clusterin isoforms in human colon tumorigenesis. Oncogene 23(13), 2298-2304.
20. Pucci, S., Bonanno, E., Pichiorri, F., Mazzarelli, P., and Spagnoli, L. G. (2004b). The expression and the nuclear activity of the caretaker gene ku86 are modulated by somatostatin. Eur. J. Histochem. 48(2), 103-110.
21. Pucci, S., Bonanno, E., Sesti, F., Mazzarelli, P., Mauriello, A., Ricci, F., Biondi Zoccai, G., Rulli, F., and Galatà, G. (2009a). Spagnoli LG Clusterin in stool: A new biomarker for colon cancer screening? Am. J. Gastroenterol. 104, 1-9.
22. Pucci, S., Mazzarelli, P., Sesti, F., Boothman, A. D., and Spagnoli, L. G. (2009b). Interleukin-6 affects cell death escaping mechanisms acting on Bax-Ku70-Clusterin interactions in human colon cancer progression. Cell Cycle 8(3), 473-481.
23. Reddy, K. B., Karode, M. C., Harmony, A. K., and Howe, P. H. (1996). Transforming growth factor beta (TGF beta)-induced nuclear localization of apolipoprotein J/clusterin in epithelial cells. Biochemistry 35, 309-314.
24. Stejskal, D., and Fiala, R. R. (2006). Evaluation of serum and urine clusterin as a potential tumor marker for urinary bladder cancer. Neoplasma 53(4), 343-346.
25. Taylor, N. P., Zighelboim, I., Huettner, P.C., Powell, M. A., Gibb, R. K., Rader, J. S., Mutch, D. G., Edmonston, T. B., and Goodfellow, P. J. (2006). DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis.Mod. Pathol. 19(10), 1333-1338.
26. Thomas-Tikhonenko, A., Viard-Leveugle, I., Dews, M., Wehrli, P., Sevignani, C., Yu, D., Ricci, S., El-Deiry, W., Aronow, B., Kaya, G., Saurat, J. H., and French, L. E. (2004). Myc-transformed epithelial cells down-regulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo. Cancer Res. 64, 3126-3136.
27. Trougakos, I. P., Poulakou, M., Stathatos, M., Chalikia, A., Melidonis, A., and Gonos, E. S. (2002). Serumlevels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction. Exp. Gerontol. 37, 1175-1187.
28. Xie, D., Sham, J., Zeng, W. F., Che, L. H., Zhang, M., Wu, H. X., Lin, H. L., Wen, J. M., Lau, H., Hu, L., and Guan, X. Y. (2005). Oncogenic role of clusterin overexpression in multistage colorectal tumorigenesis and progression. World J. Gastroenterol. 11(21), 3285-3289.
29. Yang, C. R., Yeh, S., Leskov, K., Odegaard, E., Hsu, H. L., and Chang, C. (1999). Isolation of Ku70-binding proteins (KUBs). Nucleic Acids Res. 27, 2165-2174.
30. Yang, C. R., Leskov, K., Hosley-Eberlein, K., Criswell, T., Pink, J. J., Kinsella, T. J., and Boothman, D. A. (2000). Nuclear clusterin/XIP8, an X-ray-induced Ku70-binding protein that signals cell death. Proc. Natl. Acad. Sci. USA 97, 5907-5912.